Clinical Trial Update: Metabolic Characterization of Space Occupying Lesions of the Brain

View source ↗

Summary

A clinical trial from Insel Gruppe AG and University Hospital Bern aims to metabolically characterize space-occupying brain lesions, with a focus on glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioma

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Brain Tumor, Glioma | Status: RECRUITING